Earnings NewsHealthcareAduro Biotech beats by $0.07, misses on revenueMay 02, 2017 5:16 PM ETAduro Biotech, Inc. (ADRO) StockBy: Niloofer Shaikh, SA News Editor Aduro Biotech (NASDAQ:ADRO): Q1 EPS of -$0.32 beats by $0.07. Revenue of $3.77M (-6.5% Y/Y) misses by $0.76M. Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgADRO--Aduro Biotech, Inc.Trending AnalysisTrending News